Stem cell banking provides a unique opportunity to capitalize on future advancements in stem cell technology

There are currently over 3,000 clinical studies in progress investigating the use of adult stem cells for treating degenerative diseases and healing bodily tissues. Indications with exceptional promise include Parkinson’s disease, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), spinal cord injury, macular degeneration, and osteoarthritis. Research also suggests that healthy, young stem cells may have future therapeutic potential for improving health as you age.

Banking your stem cells in their young state will give you an unparalleled opportunity to capitalize on future stem cell technology for treating disease and combating aging. By preserving your stem cells in their young state, you will ensure that you have access to healthy, viable cells when future FDA-approved stem cell technologies are available.

Founded by pioneers in stem cell preservation

Tomarrow founders Kevin Caldwell and Erik Woods have deep experience in stem cell banking. In 2016, they co-founded Ossium Health, the world’s leading bone marrow bank, which provides blood cancer patients with access to life-saving bone marrow transplants. They’re now applying their experience and technical expertise in bone marrow processing and cryopreservation and have established a new system for personalized stem cell banking at Tomarrow.


  • Co-Founder & CEO

    Prior to his work in stem cell banking at Ossium Health, Kevin served as an Engagement Manager at McKinsey’s San Francisco office where he advised clients in the biotechnology and healthcare sectors, and as a Senior Investment Associate at Bridgewater Associates where he did quantitative research for the firm’s global macro investments. Kevin studied Physics and Economics at MIT and received his JD from Harvard Law School.


  • Co-Founder & Chief Science Officer

    Erik is a leading expert in cellular cryopreservation with a proven track record of developing cell processing and banking technologies. In the decades prior to founding Ossium, Erik led a commercial cryobank, a sperm bank, and an umbilical cord blood bank. Erik is a Fellow and Past President of the Society for Cryobiology and has published numerous peer reviewed manuscripts and book chapters. Erik received his BA from Indiana University, his PhD from Purdue University, and he completed his postdoctoral research at the Indiana University School of Medicine.